Intracisternal administration of NR2 subunit antagonists attenuates the nociceptive behavior and p-p38 MAPK expression produced by compression of the trigeminal nerve root

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Jeon, Hye J ^a   Han, Seung R ^a   Lim, Koang H ^a   Won, Kyoung A ^a   Bae, Yong C ^a   Ahn, Dong K ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Compression; NR2 antagonist; p38MAPK; Trigeminal nerve root; Trigeminal neuralgia

Indexed keywords

1 (PHENANTHREN 2 CARBONYL)PIPERAZINE 2,3 DICARBOXYLIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 4 (3 PHOSPHONOPROPYL)PIPECOLIC ACID; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR NR2 BLOCKING AGENT; PENTOBARBITAL; RO 256981; UNCLASSIFIED DRUG; 4 (2' PYRIDYLDITHIO)BENZYLDIAZOACETATE; 4-(2'-PYRIDYLDITHIO)BENZYLDIAZOACETATE; DIAZONIUM COMPOUND; PHENOL DERIVATIVE; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE ROOT COMPRESSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ROTAROD TEST; SPINAL CORD DORSAL HORN; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MOTOR ACTIVITY; NOCICEPTIVE RECEPTOR; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; RADICULOPATHY; SPINAL ROOT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; DIAZONIUM COMPOUNDS; DRUG ADMINISTRATION ROUTES; MALE; MOTOR ACTIVITY; NOCICEPTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOLS; PHOSPHORYLATION; PIPERIDINES; PYRIDINES; RADICULOPATHY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL NERVE ROOTS; TRIGEMINAL NERVE; UP-REGULATION;

EID: 79958040442     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-46     Document Type: Article

References (47)

1. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999, 51:7-61.
2. Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 2007, 7:39-47. 10.1016/j.coph.2006.08.011, 17088105.
3. McBain CJ, Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 1994, 74:723-760.
4. Childers WE, Baudy RB. N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief. J Med Chem 2007, 50:2557-2562. 10.1021/jm060728b, 17489572.
5. Mori H, Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995, 34:1219-1237. 10.1016/0028-3908(95)00109-J, 8570021.
6. Yamakura T, Shimoji K. Subunit-and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 1999, 59:279-298. 10.1016/S0301-0082(99)00007-6, 10465381.
7. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001, 11:327-335. 10.1016/S0959-4388(00)00215-4, 11399431.
8. Taniguchi K, Shinjo K, Mizutani M, Shimada K, Ishikawa T, Menniti FS, Nagahisa A. Antinociceptive activity of CP-101, 606, an NMDA receptor NR2B subunit antagonist. Br J Pharmacol 1997, 122:809-812. 10.1038/sj.bjp.0701445, 1565002, 9384494.
9. Bernardi M, Bertolini A, Szczawinska K, Genedani S. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice. Eur J Pharmacol 1996, 298:51-55. 10.1016/0014-2999(95)00778-4, 8867919.
10. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG, Rupniak NM. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 1999, 38:611-623. 10.1016/S0028-3908(98)00218-4, 10340299.
11. Gaunitz C, Schüttler A, Gillen C, Allgaier C. Formalin-induced changes of NMDA receptor subunit expression in the spinal cord of the rat. Amino Acids 2002, 23:177-182. 10.1007/s00726-001-0125-3, 12373534.
12. Yang GY, Woo YW, Park MK, Bae YC, Ahn DK. Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats. J Orofac Pain 2010, 24:203-211.
13. Liu XJ, Gingrich JR, Vargas-Caballero M, Dong YN, Sengar A, Beggs S, Wang SH, Ding HK, Frankland PW, Salter MW. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat Med 2008, 14:1325-1332. 10.1038/nm.1883, 19011637.
14. Malmberg AB, Gilbert H, McCabe RT, Basbaum AI. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 2003, 101:109-116. 10.1016/S0304-3959(02)00303-2, 12507705.
15. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002, 5:1039-1042. 10.1038/nn936, 12403981.
16. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain-multiple drug targets and multiple uses. Curr Pharm Des 2005, 11:2977-2994. 10.2174/1381612054865082, 16178757.
17. Crown ED, Gwak YS, Ye Z, Johnson KM, Hulsebosch CE. Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury. Exp Neurol 2008, 213:257-267. 10.1016/j.expneurol.2008.05.025, 2580737, 18590729.
18. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003, 23:4017-4022.
19. Piao ZG, Cho IH, Park CK, Hong JP, Choi SY, Lee SJ, Lee S, Park K, Kim JS, Oh SB. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 2006, 121:219-231. 10.1016/j.pain.2005.12.023, 16495005.
20. Ahn DK, Lim EJ, Kim BC, Yang GY, Lee MK, Ju JS, Han SR, Bae YC. Compression of the trigeminal ganglion produces prolonged nociceptive behavior in rats. Eur J Pain 2009, 13:568-575. 10.1016/j.ejpain.2008.07.008, 18774318.
21. Jannetta PJ. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J Neurosurg 1967, 26:159-162. 10.3171/jns.1967.26.1part2.0159, 6018932.
22. Kitt CA, Gruber K, Davis M, Woolf CJ, Levine JD. Trigeminal neuralgia: opportunities for research and treatment. Pain 2000, 85:3-7. 10.1016/S0304-3959(99)00310-3, 10692597.
23. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001, 124:2347-2360. 10.1093/brain/124.12.2347, 11701590.
24. Zakrzewska JM, Lopez BC, Kim SE, Coakham HB. Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia. Neurosurgery 2005, 56:1304-1312. 10.1227/01.NEU.0000159883.35957.E0, 15918947.
25. McLaughlin MR, Jannetta PJ, Clyde BL, Subach BR, Comey CH, Resnick DK. Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 1999, 90:1-8. 10.3171/jns.1999.90.1.0001, 10413149.
26. Wang S, Lim G, Zeng Q, Sung B, Yang L, Mao J. Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 2005, 25:488-495. 10.1523/JNEUROSCI.4127-04.2005, 15647493.
27. Nagy GG, Watanabe M, Fukaya M, Todd AJ. Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur J Neurosci 2004, 20:3301-3312. 10.1111/j.1460-9568.2004.03798.x, 15610162.
28. Momiyama A. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord. J Physiol 2000, 523:621-628. 10.1111/j.1469-7793.2000.t01-1-00621.x, 2269820, 10718742.
29. Tong CK, Kaftan EJ, Macdermott AB. Functional identification of NR2 subunits contributing to NMDA receptors on substance P receptor-expressing dorsal horn neurons. Mol Pain 2008, 4:44-54. 10.1186/1744-8069-4-44, 2572590, 18847474.
30. Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 2009, 459:703-707. 10.1038/nature07993, 2711440, 19404260.
31. Wen YR, Suter MR, Kawasaki Y, Huang J, Pertin M, Kohno T, Berde CB, Decosterd I, Ji RR. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 2007, 107:312-321. 10.1097/01.anes.0000270759.11086.e7, 17667577.
32. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997, 386:721-724. 10.1038/386721a0, 9109489.
33. Ma QP, Hargreaves RJ. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 2000, 101:699-707. 10.1016/S0306-4522(00)00419-X, 11113318.
34. Ultenius C, Linderoth B, Meyerson BA, Wallin J. Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 2006, 399:85-90. 10.1016/j.neulet.2006.01.018, 16469445.
35. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res 1987, 424:402-406. 10.1016/0006-8993(87)91487-9, 2823998.
36. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987, 26:1235-1238. 10.1016/0028-3908(87)90275-9, 2821443.
37. Fisher K, Coderre TJ, Hagen NA. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 2000, 20:358-373. 10.1016/S0885-3924(00)00213-X, 11068158.
38. Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 2000, 16(Suppl 2):S73-79.
39. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 2001, 22:636-642. 10.1016/S0165-6147(00)01863-0, 11730974.
40. Ahn DK, Lee SY, Han SR, Ju JS, Yang GY, Lee MK, Youn DH, Bae YC. Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats. Pain 2009, 146:114-120. 10.1016/j.pain.2009.07.012, 19665300.
41. Vos BP, Strassman AM, Maciewicz RJ. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci 1994, 14:2708-2723.
42. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976, 17:1031-1036. 10.1016/0031-9384(76)90029-9, 14677603.
43. Ahn DK, Kim YS, Park JS. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett 1998, 243:105-108. 10.1016/S0304-3940(98)00099-8, 9535124.
44. Ahn DK, Chae JM, Choi HS, Kyung HM, Kwon OW, Park HS, Youn DH, Bae YC. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats. Pain 2005, 117:204-213. 10.1016/j.pain.2005.06.009, 16098663.
45. Wang XM, Zhang ZJ, Bains R, Mokha SS. Effect of antisense knock-down of alpha(2a)-and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Pain 2002, 98:27-35. 10.1016/S0304-3959(01)00464-X, 12098614.
46. Ahn DK, Choi HS, Yeo SP, Woo YW, Lee MK, Yang GY, Jeon HJ, Park JS, Mokha SS. Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception. Pain 2007, 132:23-32. 10.1016/j.pain.2007.01.015, 17321048.
47. Han SR, Lee MK, Lim KH, Yang GY, Jeon HJ, Ju JS, Yoon YW, Kim SK, Ahn DK. Intramuscular administration of morphine reduces mustard oil-induced craniofacial muscle pain behavior in lightly anesthetized rats. Eur J Pain 2008, 12:361-370. 10.1016/j.ejpain.2007.07.002, 17768078.